Article By:
Jeff Nielson
Wednesday, July 7, 2021 11:01 AM EDT
Drug R&D in the emerging psychedelic drug industry continues to advance. Share prices continue to lag. Here's a comparison of the strengths and weaknesses of six of the leaders in psychedelic drug R&D among public companies.